CMA CGM and ENGIE plan biomethane plant: ENGIE stock sits 19.41 percent below EUR 29 target
Published on 10/14/2026 at 12:00 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSRenewable gas plans gain scale
- ENGIE and CMA CGM signed a framework agreement on October 13, 2026, for a Le Havre biomethane facility.
- ENGIE targets 10 TWh of annual European biomethane capacity by 2035, up from 1.2 TWh today.
- ENGIE stock trades at EUR 23.37 at 11:55 a.m. CEST at Lang & Schwarz on October 14, 2026.
- Morgan Stanley cut its ENGIE target from EUR 31 to EUR 29 on October 7, 2026.
ENGIE (ISIN FR0010208488) is trading at EUR 23.37 at Lang & Schwarz on October 14, 2026 at 11:55 a.m. CEST. The latest company catalyst is a framework agreement with CMA CGM for a biomethane facility in Le Havre, signed on October 13, 2026, according to CMA CGM.
A 100 GWh fuel project
The facility is designed to supply 7,000 tons, equivalent to 100 GWh, of biomethane annually from 2029. The partners estimate that the fuel could avoid 23,000 tons of CO2 emissions each year, while lifecycle greenhouse-gas emissions would fall by at least 67 percent compared with conventional marine fuels, CMA CGM said on October 13, 2026.
ENGIE will lead technical design and permitting, while CMA CGM will invest as a minority shareholder through its PULSE energy fund. The project supports ENGIE's target of 10 TWh of annual biomethane production capacity in Europe by 2035, compared with 1.2 TWh today.
What does the target mean?
Morgan Stanley cut its ENGIE price target from EUR 31 to EUR 29 on October 7, 2026, while retaining an Overweight rating, Yahoo Finance reported. Against the EUR 23.37 Lang & Schwarz price, the revised target is 24.08 percent above the price.
Three dated steps for ENGIE
On July 31, 2026, ENGIE published first-half results and upgraded its 2026 recurring net income guidance to EUR 4.9 billion-EUR 5.5 billion from EUR 4.6 billion-EUR 5.2 billion, according to Yahoo Finance. On September 30, 2026, ENGIE and the Belgian State postponed nuclear negotiations to November 4, 2026, according to ENGIE. The October 13, 2026 biomethane agreement is the newest step.
Two dates shape the next update
The Belgian nuclear Heads of Terms target is November 4, 2026, according to ENGIE. The company lists November 5, 2026, for publication of its nine-month 2026 financial results on its investor page.
Stock and strategy in view
At EUR 23.37, the market price sits below Morgan Stanley's revised EUR 29 target, while the new renewable-gas project adds a concrete operating milestone to ENGIE's longer-term capacity plan. The next reported results and the Belgian nuclear timetable offer separate tests for execution and capital allocation.
The further course of trading is shown by the continuously updated real-time quote of ENGIE stock.
ENGIE stock key facts
- Company: ENGIE S.A.
- ISIN: FR0010208488
- WKN: A0ER6Q
- Ticker: GZF
- Primary exchange: Xetra
- Price Lang & Schwarz (as of October 14, 2026, 11:55 a.m. CEST): EUR 23.37
- Sector / Industry: Utilities / Diversified Utilities
Market context: Market report DAX.
